RadNet Inc (RDNT)

Currency in USD
54.15
-0.26(-0.47%)
Real-time Data·
RDNT is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
54.1555.20
52 wk Range
50.7685.84
Key Statistics
Prev. Close
54.4
Open
54.75
Day's Range
54.15-55.2
52 wk Range
50.76-85.84
Volume
64.69K
Average Volume (3m)
881.85K
1-Year Change
-3.9922%
Book Value / Share
13.92
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
RDNT Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
89.75
Upside
+65.74%
Members' Sentiments
Bearish
Bullish
ProTips
Trading near 52-week low

RadNet Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Analyst Ratings

8 Buy
0 Hold
0 Sell
Ratings:
8 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 89.75
(+65.74% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Barclays
Buy65.00+19.90%70.00Maintain20/05/2026
B.Riley
Buy83.00+53.11%87.00Maintain01/05/2026
KeyBanc
Buy92.00+69.71%-Maintain29/04/2026
Barclays
Buy70.00+29.13%86.00Maintain20/04/2026
Jefferies
Buy91.00+67.87%-Maintain03/03/2026

RadNet Inc SWOT Analysis


Imaging Innovato
RadNet's strategic acquisition of iCAD for $103 million positions the company at the forefront of AI-driven diagnostic imaging technology
Financial Resilience
Despite weather-related challenges, RadNet demonstrates robust performance with revenue beats and raised guidance, showcasing operational adaptability
Market Valuation
Analyst targets range from $71 to $92 per share, reflecting optimism about RadNet's growth prospects and market positioning in healthcare technology
Future Growth Drivers
Explore RadNet's potential for margin expansion through operational efficiencies, AI integration, and the acceleration of its DeepHealth segment
Read full SWOT analysis

RadNet Inc Earnings Call Summary for Q1/2026

  • RadNet Q1 2026 revenue rose 22.1% YoY to record $575.63M; adjusted EBITDA grew 36.3% with margin expansion of 115 basis points.
  • EPS of -$0.28 missed forecast of -$0.15 by 86.67%; stock dropped 3.76% after-hours to $56, reflecting investor disappointment.
  • Digital health segment revenue surged 51.5% YoY, driven by strategic acquisitions including iCAD and Gleamer.
  • Company targets $114M+ annual recurring revenue by end of 2026; analysts forecast profitability with $0.63 EPS for FY2026.
  • Severe weather disrupted Q1 operations; CEO cited record growth despite challenges, emphasizing digital health innovations driving stakeholder value.
Last Updated: 18/05/2026, 08:50
Read Full Transcript

Earnings

Latest Release
11/05/2026
EPS / Forecast
-0.28 / -0.15
Revenue / Forecast
575.63M / 557.64M
EPS Revisions
Last 90 days

RadNet (RDNT) Income Statement & Profits

Compare RDNT to Peers and Sector

Metrics to compare
RDNT
Peers
Sector
Relationship
P/E Ratio
−301.4x6.1x−0.5x
PEG Ratio
−5.330.350.00
Price/Book
4.0x3.4x2.6x
Price / LTM Sales
2.0x1.2x3.1x
Upside (Analyst Target)
71.9%36.6%52.5%
Fair Value Upside
Unlock23.5%6.0%Unlock

RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States and internationally. The company operates in two segments, Imaging Centers and Digital Health. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretations of breast, lung, and prostate images, as well as solutions for prostate cancer screening. In addition, it develops and delivers AI-powered health informatics solutions to drive quality, efficiency, and outcomes in imaging and radiology; informatics designed for outpatient radiology; and DeepHealth OS, a cloud-native operating system that helps in the operations of the radiology service. RadNet, Inc. was founded in 1981 and is headquartered in Los Angeles, California.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
40.23M51.16%2.19B
Other Institutional Investors
38.32M48.73%2.08B
Public Companies & Retail Investors
88.64K0.11%4.82M
Total
78.63M100.00%4.28B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
BlackRock, Inc.12.76%10,035,734545,944
The Vanguard Group, Inc.9.49%7,463,101405,993

People Also Watch

91.20
PATK
+0.89%
37.73
ROCK
+1.48%
51.82
MSEX
-0.56%
1.125
SPWR
+0.45%
55.40
FHI
+1.08%

FAQ

What Is the RadNet (NASDAQ: RDNT) Share Price Today?

The RadNet stock price today is 54.15 USD.

What Stock Exchange Does RadNet (RDNT) Trade On?

RadNet is listed and trades on the Nasdaq Stock Exchange.

What Is the Ticker (Stock Symbol) for RadNet?

The stock symbol (also called a 'ticker') for RadNet is "RDNT."

What Is the Current RadNet Market Capitalisation?

As of today, RadNet (NASDAQ: RDNT) market cap is 4.28B USD.

What Is RadNet's (RDNT) Earnings Per Share (TTM)?

The RadNet EPS is currently -0.19 (Trailing Twelve Months).

When Is the Next RadNet Earnings Date?

RadNet's next earnings report will be released on 11/08/2026.

Is RDNT a Buy or Sell From a Technical Analyst Perspective?

Based on today's RadNet moving averages and other technical indicators, the daily buy/sell signal for RDNT stock is Strong Sell.

How Many Times Has RadNet Stock Split?

RadNet has split 1 times. (See the RDNT stock split history page for full effective split date and price information.)

How Many Employees Does RadNet Have?

RadNet has 9060 employees, based on their latest Companies House report.

What is the current trading status of RadNet (NASDAQ: RDNT)?

As of 26/05/2026, RadNet (RDNT) is trading at a share price of 54.15 USD, with a previous close of 54.40 USD. The stock has fluctuated within a day range of 54.15 USD to 55.20 USD, while its 52-week range spans from 50.76 USD to 85.84 USD.

What Is RadNet (RDNT) Price Target According to Analysts?

The average 12-month price target for RadNet is 89.75 USD, with a high estimate of 100 USD and a low estimate of 65 USD. 8 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +65.74% Upside potential.

What Is the RDNT Premarket Price?

RDNT's last pre-market stock price is 54.57 USD. The pre-market share volume is 10.00, and the stock has decreased by 0.17, or 0.31%.

What Is the RDNT After Hours Price?

RDNT's last after hours stock price is 53.35 USD, the stock has decreased by -1.05, or -1.93%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.